"Tumors that spread, or metastasize, in the body shed cells into blood that doctors can scrutinize for insights into what a patient’s cancer might do. Analyzing these so-called circulating tumor cells (CTCs) isn’t part of routine care yet, in part because they’re so hard to pick out of the millions of normal cells in a blood sample." Read more...
New blood test may someday help guide the best treatment for aggressive prostate cancer .
Posted August 01, 2018.Charlie Schmidt .Harvard Medical School Annual Report on Prostate Diseases.
